ArticleBMC pulmonary medicine2021

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.